Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Abrocitinib
76%
Atopic Dermatitis
73%
Moderate-to-severe Atopic Dermatitis
68%
Dupilumab
40%
Itch
38%
Plaque Psoriasis
34%
Placebo
29%
Monotherapy
27%
Quality of Life
24%
Basal Cell Carcinoma
23%
Investigator's Global Assessment
23%
Rapid Improvement
21%
5-fluorouracil (5-FU)
21%
Dermatological Diseases
21%
Consensus Panel
21%
Expert Consensus
21%
Area Index
20%
Severity Index
20%
Eczema
20%
Once-daily
19%
Upadacitinib
17%
Janus Kinase 1 (JAK1)
16%
Forearm
16%
Pruritus
16%
Actinic Keratosis
15%
Moderate-to-severe Psoriasis
15%
Randomized Controlled Trial
15%
Clinical Outcomes
15%
Laboratory Monitoring
14%
Hydroxychloroquine
14%
Skin Cancer
14%
Non-responders
14%
Interleukin-13 (IL-13)
14%
Confocal Microscopy
13%
Dermatologic Surgery
12%
Systematic Literature Review
12%
Patient Experience
12%
Tralokinumab
12%
Topical Corticosteroids
10%
Intralesional
10%
Contemporary Approaches
10%
Pilocarpine Model
10%
Pathophysiology
10%
Laser-assisted
10%
Reflectance Confocal Microscopy
10%
Tapinarof
10%
Disease Association
10%
Epidemiology
10%
Ulcer
10%
Systemic Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
100%
Pruritus
50%
Psoriasis Vulgaris
43%
Placebo
41%
Diseases
40%
Dupilumab
39%
Monotherapy
28%
Adverse Event
25%
Dermatological Agent
23%
Basal Cell Carcinoma
23%
Psoriasis
23%
Eczema
21%
Malignant Neoplasm
18%
Physical Disease by Body Function
16%
Upadacitinib
16%
Biological Product
13%
Squamous Cell Carcinoma
12%
Randomized Controlled Trial
12%
Tralokinumab
12%
Clinical Trial
11%
Disease Association
10%
Topical Corticosteroid
10%
Pathophysiology
10%
Tapinarof
10%
Toxic Epidermal Necrolysis
10%
Rhizopus
10%
Fluorouracil
10%
Hydroxychloroquine
10%
Papillomavirus Infection
10%
Arthralgia
10%
Guselkumab
10%
Secukinumab
8%
Adalimumab
8%
Ixekizumab
8%
Human Papillomavirus
8%
Comorbidity
7%
Janus Kinase 1
6%
Combination Therapy
5%
Medicine and Dentistry
Diseases
43%
Psoriasis Vulgaris
43%
Dermatological Agent
40%
Atopic Dermatitis
34%
Pruritus
25%
Basal-Cell Carcinoma
23%
Systematic Review
23%
Psoriasis
23%
Fluorouracil
21%
Placebo
19%
Health Care Cost
17%
Skin Surgery
16%
Skin Cancer
16%
Actinic Keratosis
16%
Adverse Event
14%
Patient-Reported Outcome
12%
Confocal Microscopy
12%
Biological Product
12%
Disease Association
10%
Mohs Surgery
10%
Subgroup Analysis
10%
Pemetrexed
10%
Cohort Effect
10%
Lentigo Maligna
10%
Reflectance Confocal Microscopy
10%
Tapinarof
10%
Ulcer
10%
Arm
10%
Patient Experience
10%
Dupilumab
10%
Pathophysiology
10%
Molecularly Targeted Therapy
10%
Full Thickness Skin Graft
10%
Suture
10%
Melanoma
10%
Interleukin 13
10%
Guselkumab
10%
Clinical Trial
9%
Physical Examination
9%
Quality of Life
9%
Adalimumab
8%
Ixekizumab
8%
Secukinumab
8%
Eczema
8%
Oral
7%
Comorbidity
7%
Malignant Neoplasm
7%
Continuing Medical Education
7%
Dermatology Life Quality Index
5%
Topical Corticosteroid
5%
